Folgen
Nichola R Naylor
Nichola R Naylor
OIPP
Bestätigte E-Mail-Adresse bei oipharmapartners.com
Titel
Zitiert von
Zitiert von
Jahr
Estimating the burden of antimicrobial resistance: a systematic literature review
NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ...
Antimicrobial Resistance & Infection Control 7, 1-17, 2018
5992018
Quantifying drivers of antibiotic resistance in humans: a systematic review
A Chatterjee, M Modarai, NR Naylor, SE Boyd, R Atun, J Barlow, ...
The Lancet Infectious Diseases 18 (12), e368-e378, 2018
3652018
The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study
NR Naylor, KB Pouwels, R Hope, N Green, KL Henderson, GM Knight, ...
PloS one 14 (9), e0221944, 2019
842019
Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: a probabilistic modelling study
DRM Smith, KB Pouwels, S Hopkins, NR Naylor, T Smieszek, ...
Journal of Hospital Infection 103 (1), 44-54, 2019
662019
Is antimicrobial stewardship cost-effective? A narrative review of the evidence
NR Naylor, N Zhu, M Hulscher, A Holmes, R Ahmad, JV Robotham
Clinical Microbiology and Infection 23 (11), 806-811, 2017
662017
The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: A systematic literature review
DM Youssef, B Wieland, GM Knight, J Lines, NR Naylor
Zoonoses and public health 68 (6), 549-562, 2021
532021
Antibiotic prescribing in general medical and surgical specialties: a prospective cohort study
E Charani, E De Barra, TM Rawson, D Gill, M Gilchrist, NR Naylor, ...
Antimicrobial Resistance & Infection Control 8, 1-10, 2019
482019
Mapping national surveillance of surgical site infections in England: needs and priorities
R Troughton, G Birgand, AP Johnson, N Naylor, M Gharbi, P Aylin, ...
Journal of Hospital Infection 100 (4), 378-385, 2018
382018
Changing food systems and infectious disease risks in low-income and middle-income countries
J Waage, D Grace, EM Fèvre, J McDermott, J Lines, B Wieland, ...
The Lancet Planetary Health 6 (9), e760-e768, 2022
372022
Quantifying the relationship between antibiotic use in food-producing animals and antibiotic resistance in humans
D Emes, N Naylor, J Waage, G Knight
Antibiotics 11 (1), 66, 2022
332022
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
S Torres-Rueda, S Sweeney, F Bozzani, NR Naylor, T Baker, C Pearson, ...
BMJ global health 6 (12), e005759, 2021
282021
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countries
S Sweeney, TPJ Capeding, R Eggo, M Huda, M Jit, D Mudzengi, ...
BMJ global health 6 (5), e005521, 2021
252021
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe
N Hassoun-Kheir, M Guedes, MTN Nsoga, L Argante, F Arieti, ...
Clinical microbiology and infection 30, S14-S25, 2024
202024
Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England
S Mizuno, M Iwami, S Kunisawa, N Naylor, K Yamashita, Y Kyratsis, ...
Journal of Hospital Infection 100 (3), 280-298, 2018
202018
Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance
NR Naylor, J Lines, J Waage, B Wieland, GM Knight
One Health 11, 100194, 2020
192020
Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol
NR Naylor, S Silva, K Kulasabanathan, R Atun, N Zhu, GM Knight, ...
Systematic reviews 5, 1-5, 2016
172016
Vaccine value profile for Klebsiella pneumoniae
Z Dangor, N Benson, JA Berkley, J Bielicki, MW Bijsma, J Broad, ...
Vaccine, 2024
132024
Health economic evaluation using Markov models in R for Microsoft excel users: a tutorial
N Green, F Lamrock, N Naylor, J Williams, A Briggs
PharmacoEconomics 41 (1), 5-19, 2023
112023
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets
QJ Leclerc, NR Naylor, AM Aiken, F Coll, GM Knight
Wellcome Open Research 4, 140, 2020
112020
A National Estimate of the Health and Cost Burden of Escherichia coli Bacteraemia in the Hospital Setting: The Importance of Antibiotic Resistance
NR Naylor, KB Pouwels, R Hope, N Green, KL Henderson, GM Knight, ...
bioRxiv, 153775, 2017
112017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20